Avalo Therapeutics Inc (NAS:AVTX)
$ 17.68 -0.33 (-1.81%) Market Cap: 929.10 Mil Enterprise Value: 847.43 Mil PE Ratio: 0 PB Ratio: 6.38 GF Score: 23/100

Avalo Therapeutics Inc at TD Cowen Healthcare Conference Transcript

Mar 3, 2026 / 02:50 PM GMT
Release Date Price: $18.85 (+4.84%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

AVTX.OQ - Avalo Therapeutics Inc
Avalo Therapeutics Inc at TD Cowen Healthcare Conference
Mar 03, 2026 / 02:50PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Thanks so much for joining our forty-sixth annual health care conference. I'm Stacy K, part of the biotech team with my colleague, Vish Shah, and we're very happy to be hosting Avalo Therapeutics with us today. We have Gary Neale, CEO, and and in the crowd joining us is CFO Chris Sullivan. So really thanks to everyone for coming today. So.

A lot of interest in your asset, a lot of focus, a lot of investor inbounds these days. I'm sure you guys are getting the heat as well, so we do know there's a much higher, understanding of the, of your asset in the background, but just remind us what's the strategy for ABTX 009. And you, and your, let's say potential in HS.

-----------------------------------------
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot